168 related articles for article (PubMed ID: 38072367)
1. Therapeutic effects of in vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study.
Chuang TD; Ton N; Rysling S; Quintanilla D; Boos D; Khorram O
Fertil Steril; 2024 Apr; 121(4):669-678. PubMed ID: 38072367
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan catabolism is dysregulated in leiomyomas.
Chuang TD; Quintanilla D; Boos D; Khorram O
Fertil Steril; 2021 Oct; 116(4):1160-1171. PubMed ID: 34116832
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan 2,3-dioxygenase 2 plays a key role in regulating the activation of fibroblast-like synoviocytes in autoimmune arthritis.
Chang Y; Han P; Wang Y; Jia C; Zhang B; Zhao Y; Li S; Li S; Wang X; Yang X; Wei W
Br J Pharmacol; 2022 Jun; 179(12):3024-3042. PubMed ID: 34969166
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effects of Long-Term Administration of Tranilast in an Animal Model for the Treatment of Fibroids.
Chuang TD; Munoz L; Quintanilla D; Boos D; Khorram O
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445642
[TBL] [Abstract][Full Text] [Related]
5. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.
Abuin-Martínez C; Vidal R; Gutiérrez-López MD; Pérez-Hernández M; Giménez-Gómez P; Morales-Puerto N; O'Shea E; Colado MI
Neuropharmacology; 2021 Apr; 187():108490. PubMed ID: 33607146
[TBL] [Abstract][Full Text] [Related]
6. Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation.
Imbeault S; Goiny M; Liu X; Erhardt S
Acta Neuropsychiatr; 2020 Feb; 32(1):43-53. PubMed ID: 31753057
[TBL] [Abstract][Full Text] [Related]
7. MED12 mutation activates the tryptophan/kynurenine/AHR pathway to promote growth of uterine leiomyomas.
Zuberi A; Huang Y; Dotts AJ; Wei H; Coon JS; Liu S; Iizuka T; Wu O; Sotos O; Saini P; Chakravarti D; Boyer TG; Dai Y; Bulun SE; Yin P
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37607000
[TBL] [Abstract][Full Text] [Related]
8. Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model.
Chuang TD; Ton N; Manrique N; Rysling S; Khorram O
Clin Sci (Lond); 2024 May; ():. PubMed ID: 38817011
[TBL] [Abstract][Full Text] [Related]
9. The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat.
Salter M; Hazelwood R; Pogson CI; Iyer R; Madge DJ
Biochem Pharmacol; 1995 May; 49(10):1435-42. PubMed ID: 7539265
[TBL] [Abstract][Full Text] [Related]
10. Further characterization of tryptophan metabolism and its dysregulation in fibroids.
Chuang TD; Quintanilla D; Boos D; Khorram O
F S Sci; 2022 Nov; 3(4):392-400. PubMed ID: 35715314
[TBL] [Abstract][Full Text] [Related]
11. Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition.
Dos Santos IL; Mitchell M; Nogueira PAS; Lafita-Navarro MC; Perez-Castro L; Eriom J; Kilgore JA; Williams NS; Guo L; Xu L; Conacci-Sorrell M
FEBS J; 2024 May; 291(10):2172-2190. PubMed ID: 38431776
[TBL] [Abstract][Full Text] [Related]
12. Kynurenine produced by tryptophan 2,3-dioxygenase metabolism promotes glioma progression through an aryl hydrocarbon receptor-dependent signaling pathway.
Ma W; Ye L; Zhong C; Li J; Ye F; Lv L; Yu Y; Jiang S; Zhou P
Cell Biol Int; 2022 Oct; 46(10):1577-1587. PubMed ID: 35702760
[TBL] [Abstract][Full Text] [Related]
13. TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling.
Ding X; Jin Y; Shi X; Wang Y; Jin Z; Yin L; Gao S; Lei Y; Yang J
Biochem Pharmacol; 2024 May; 223():116172. PubMed ID: 38552852
[TBL] [Abstract][Full Text] [Related]
14. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner.
Li F; Zhao Z; Zhang Z; Zhang Y; Guan W
BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and regulation of Tdo2 during mouse decidualization.
Li DD; Gao YJ; Tian XC; Yang ZQ; Cao H; Zhang QL; Guo B; Yue ZP
J Endocrinol; 2014 Jan; 220(1):73-83. PubMed ID: 24190896
[TBL] [Abstract][Full Text] [Related]
17. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
[TBL] [Abstract][Full Text] [Related]
18. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma.
Mohapatra SR; Sadik A; Tykocinski LO; Dietze J; Poschet G; Heiland I; Opitz CA
Front Immunol; 2019; 10():2762. PubMed ID: 31866995
[TBL] [Abstract][Full Text] [Related]
20. EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.
Mutz CN; Schwentner R; Kauer MO; Katschnig AM; Kromp F; Aryee DN; Erhardt S; Goiny M; Alonso J; Fuchs D; Kovar H
FEBS Lett; 2016 Jul; 590(14):2063-75. PubMed ID: 27282934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]